Apollomics (APLM) Common Equity (2022 - 2025)

Apollomics has reported Common Equity over the past 4 years, most recently at -$3.2 million for Q4 2025.

  • Quarterly Common Equity fell 165.54% to -$3.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.2 million through Dec 2025, down 165.54% year-over-year, with the annual reading at -$3.2 million for FY2025, 165.54% down from the prior year.
  • Common Equity was -$3.2 million for Q4 2025 at Apollomics, down from $4.9 million in the prior quarter.
  • Over five years, Common Equity peaked at $41.2 million in Q4 2023 and troughed at -$448.1 million in Q4 2022.
  • The 4-year median for Common Equity is $838000.0 (2024), against an average of -$101.3 million.
  • Biggest five-year swings in Common Equity: skyrocketed 109.2% in 2023 and later plummeted 165.54% in 2025.
  • Tracing APLM's Common Equity over 4 years: stood at -$448.1 million in 2022, then skyrocketed by 109.2% to $41.2 million in 2023, then plummeted by 88.2% to $4.9 million in 2024, then plummeted by 165.54% to -$3.2 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at -$3.2 million, $4.9 million, and $41.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.